- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | Syndax shares fall 17% after calling it quits on Niktimvo fibrosis program | ||
| Di | BARDA awards Kaléo $96M contract to deploy auto-injector for chemical threat preparedness | ||
| Di | ARPA-H program manager talks 'first-shoring' philosophy behind $125M RNA manufacturing network challenge | ||
| Di | UCB fashions 'Wear It Out' project with empowering t-shirts, community for inflammatory disease patients | ||
| Di | Galderma sculpts new narrative around menopausal skin changes to fill awareness gap | ||
| 12.10. | Data Precision Is Healthcare Marketing's Growth Engine | ||
| 12.10. | Mirum on its way to 3rd rare liver indication for Livmarli | ||
| 12.10. | Why Timing Has Become HCP Marketing's Biggest Challenge | ||
| 12.10. | Bausch + Lomb names Appio interim CEO as Saunders hits the exit again | ||
| 12.10. | Invenra deals patient perspectives into the ADC game with custom card deck | ||
| 12.10. | Asahi Kasei buyout yields novel FDA herpes nod in immunocompromised patients | ||
| 12.10. | Media OS is designed to tackle healthcare advertising's identity challenge | ||
| 12.10. | Why Patient Voice Must Shape Pharma Strategy | ||
| 12.10. | Par Health recalls more IV bags on cellulose risk weeks after similar action | ||
| 12.10. | UCB's Bimzelx takes top drug ad spending spot as streaming data come to the fore | ||
| 12.10. | AI, Data and the New Rules of HCP Marketing | ||
| 12.10. | How Ohio Is Building a Biopharma Growth Engine | ||
| 12.10. | AI-Powered Brand Sites Are Changing Patient Engagement | ||
| 12.10. | Why Medical Teams Must Lead DOL Strategy | ||
| 12.10. | RevHealth's Chris Cullmann on AI and Human-Centered Pharma | ||
| 12.10. | How Predictive Modeling Uncovers Blind Spots in the Patient Journey | ||
| 12.10. | Why AI's Biggest Value in Pharma Is Confidence | ||
| 12.10. | Executive Interviews at Fierce Pharma Week 2026 | ||
| 12.10. | Fullspan Health on Winning the AI Search Revolution | ||
| 12.10. | Why AI and Precision Matter in Pharma Commercialization |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.